EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Neurodegeneration and demyelination in multiple sclerosis

Thomas Garton, Sachin P Gadani, Alexander J Gill, Peter A Calabresi

Neuron · 2024-10 · 112 (19) · 3231-3251

DOI: 10.1016/j.neuron.2024.05.025 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Neuron, 2024-10. Verfasst von Thomas Garton und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Neuroimmunology, Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA. Hauptthemen laut MEDLINE: Multiple Sclerosis, Demyelinating Diseases. Die Arbeit wurde bisher 124-mal zitiert (Crossref) und nennt 253 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NINDS NIH HHS, NIGMS NIH HHS, NINDS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Progressive multiple sclerosis (PMS) is an immune-initiated neurodegenerative condition that lacks effective therapies. Although peripheral immune infiltration is a hallmark of relapsing-remitting MS (RRMS), PMS is associated with chronic, tissue-restricted inflammation and disease-associated reactive glial states. The effector functions of disease-associated microglia, astrocytes, and oligodendrocyte lineage cells are beginning to be defined, and recent studies have made significant progress in uncovering their pathologic implications. In this review, we discuss the immune-glia interactions that underlie demyelination, failed remyelination, and neurodegeneration with a focus on PMS. We highlight the common and divergent immune mechanisms by which glial cells acquire disease-associated phenotypes. Finally, we discuss recent advances that have revealed promising novel therapeutic targets for the treatment of PMS and other neurodegenerative diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Multiple SclerosisDemyelinating DiseasesHumansAnimalsNeurogliaMicrogliaAstrocytesOligodendrogliaNerve DegenerationNeurodegenerative DiseasesRemyelination

Stichwörter der Autor:innen

astrocyteschronic inflammationcomplementinhibitory factorsmicroglianeuroprotectionoligodendrocytesprogressive multiple sclerosisreactive gliaremyelination

Autor:innen und Institutionen

  • Division of Neuroimmunology, Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Division of Neuroimmunology, Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA. Electronic address: pcalabr1@jhmi.edu.

Förderung

  • NINDS NIH HHS
  • NIGMS NIH HHS
  • NINDS
  • National Multiple Sclerosis Society
  • American Brain Foundation
  • National Institutes of Health
  • Johns Hopkins University
  • U.S. Department of Defense

Zitieren

APA

Garton, T., Gadani, S. P., Gill, A. J., & Calabresi, P. A. (2024). Neurodegeneration and demyelination in multiple sclerosis. Neuron, 112(19), 3231-3251. https://doi.org/10.1016/j.neuron.2024.05.025

Vancouver

Garton T, Gadani SP, Gill AJ, Calabresi PA. Neurodegeneration and demyelination in multiple sclerosis. Neuron. 2024;112(19):3231-3251. doi:10.1016/j.neuron.2024.05.025

BibTeX
@article{Garton2024,
  author = {Garton, Thomas and Gadani, Sachin P and Gill, Alexander J and Calabresi, Peter A},
  title = {Neurodegeneration and demyelination in multiple sclerosis},
  journal = {Neuron},
  year = {2024},
  volume = {112},
  number = {19},
  pages = {3231--3251},
  doi = {10.1016/j.neuron.2024.05.025}
}
Kostenlos starten →